Dr. Kuzmich is the Managing Partner at Haug Partners. Her practice focuses on patent litigation and strategic intellectual property counseling in the areas of pharmaceuticals, chemicals, and biotechnology. Recognizing that product life-cycle management is continuous and dynamic, she develops, manages, and protects diverse patent portfolios, taking into consideration a client’s immediate and long-term business objectives. Her extensive experience in pharmaceutical patent litigation allows her to offer a distinctive approach to protecting and maximizing the value of intellectual property assets. She specializes in counseling clients on how to obtain strong and diverse intellectual property protection on pharmaceuticals and biological products during early research, and how to expand and defend that protection throughout development, product launch, and beyond.
Upon completion of her graduate degree in pharmacology, Dr. Kuzmich became a post-doctoral research associate with the Fox Chase Cancer Center where she investigated mechanisms of anti-cancer drug resistance. She spent several years in the private pharmaceutical sector, managing departments in the U.S. in the areas of drug metabolism and pharmacokinetics, and also collaborating with Asian and European counterparts to coordinate worldwide regulatory submissions.
Dr. Kuzmich serves on the Board of Directors for the Federal Circuit Bar Association, which includes being a frequent lecturer at various international conferences throughout the year.